Codeine

Codeine

SCHEMBL7775792

CCCCCCCCCCCC(=O)O.COc1ccc2c3c1O[C@H]1[C@@H](O)C=C[C@H]4[C@@H](C2)N(C)CC[C@@]341

nearest known ligand 0.77

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRD1OPRK1OPRM1

The experimentally established mechanism targets of Codeine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ OPRM1 known ✓ P35372 8/20 0.77
▸ OPRD1 known ✓ P41143 8/20 0.77
▸ OPRK1 known ✓ P41145 6/20 0.77
▸ MRGPRX2 Q96LB1 4/20 0.77
▸ ADRB1 P08588 1/20 0.77
▸ PDE4D Q08499 1/20 0.77
▸ PDE3A Q14432 1/20 0.77
▸ SLC22A1 O15245 1/20 0.59
▸ ADRA2A P08913 1/20 0.59
▸ ARRB1 P49407 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Codeine SCHEMBL7770906 1.00 OPRM1 (0.77) OPRM1OPRD1OPRK1MRGPRX2ADRB1
Codeine SCHEMBL3477475 1.00 OPRM1 (0.77) OPRM1OPRD1OPRK1MRGPRX2ADRB1
Codeine SCHEMBL3477724 0.97 OPRM1 (0.79) OPRM1OPRD1OPRK1MRGPRX2ADRB1
Morphine SCHEMBL22234325 0.90 OPRD1 (0.75) OPRM1OPRD1OPRK1MRGPRX2SLC22A1
Morphine SCHEMBL3476234 0.90 OPRD1 (0.75) OPRM1OPRD1OPRK1MRGPRX2SLC22A1
Codeine SCHEMBL2322854 0.89 OPRM1 (0.86) OPRM1OPRD1OPRK1MRGPRX2ADRB1
SCHEMBL3476236 0.89 OPRD1 (0.68) OPRM1OPRD1OPRK1MRGPRX2ADRB1
Codeine SCHEMBL3476555 0.89 OPRD1 (0.91) OPRM1OPRD1OPRK1MRGPRX2ADRB1
Codeine SCHEMBL13998952 0.88 OPRD1 (1.00) OPRM1OPRD1OPRK1MRGPRX2ADRB1
Codeine SCHEMBL14192921 0.88 OPRD1 (1.00) OPRM1OPRD1OPRK1MRGPRX2ADRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6255502-B1 DRUG DELIVERY THROUGH SKIN, INTESTINAL, ORAL, NASAL, AND RECTAL MUCOSA ENHANCED BY FORMING INCLUSION COMPLEXES WITH CYCLODEXTRINS (SOLUBILIZERS/STABILIZERS) AND ACID-ADDITION SALTS OF DRUGS (CODEINE) AND A FATTY/BILE ACID FARMARC NEDERLAND B.V. (NL) 2001-07-03 — — US claimed
JP-2001508027-A — — 2001-06-19 — — JP claimed
EP-1024833-A1 Pharmaceutical composition containing acid addition salt of basic drug FARMARC NEDERLAND B.V. (NL) 2000-08-09 — — EP claimed
WO-1998002187-A1 PHARMACEUTICAL COMPOSITION CONTAINING ACID ADDITION SALT OF BASIC DRUG FARMARC NEDERLAND B.V. (NL) 1998-01-22 — — WO claimed
US-6255502-B1 DRUG DELIVERY THROUGH SKIN, INTESTINAL, ORAL, NASAL, AND RECTAL MUCOSA ENHANCED BY FORMING INCLUSION COMPLEXES WITH CYCLODEXTRINS (SOLUBILIZERS/STABILIZERS) AND ACID-ADDITION SALTS OF DRUGS (CODEINE) AND A FATTY/BILE ACID FARMARC NEDERLAND B.V. (NL) 2001-07-03 — — US disclosed
EP-1024833-A1 Pharmaceutical composition containing acid addition salt of basic drug FARMARC NEDERLAND B.V. (NL) 2000-08-09 — — EP disclosed
WO-1998002187-A1 PHARMACEUTICAL COMPOSITION CONTAINING ACID ADDITION SALT OF BASIC DRUG FARMARC NEDERLAND B.V. (NL) 1998-01-22 — — WO disclosed
Send feedback